Measles in children under five: cases rose by 40% after the pandemic
Published: · Русский · O‘zbekcha
Estimates for 204 countries published in Nature Medicine show that measles cases in children under five rose from 11.1 to 15.6 million between 2019 and 2023, and one in five infants missed the first dose.

Researchers at the University of Queensland (Australia), working within the Global Burden of Disease project (GBD 2023) led by the Institute for Health Metrics and Evaluation at the University of Washington, analysed estimates of measles incidence, deaths and missed vaccination in children under five in 204 countries and territories for 1990–2023. The work was published in Nature Medicine; the university announced it on 22 October 2026.
According to the estimates, the number of measles cases worldwide fell by almost 80% between 1990 and 2019. After the COVID-19 pandemic the trend reversed: from 2019 to 2023 the estimated number of cases in children under five rose by 40%, from 11.1 to 15.6 million. In 2023 about 23.7 million infants — roughly one in five — did not receive the first dose of the vaccine. Half of the missed doses were in sub-Saharan Africa and another 20% in South Asia.
Two doses of the childhood vaccine are estimated to have prevented almost 59 million deaths between 2000 and 2024. The study lead, Associate Professor Benn Sartorius, calls for restoring routine immunization and running targeted catch-up vaccination. These are model estimates, not a direct count of every case.
Source: University of Queensland (по исследованию в Nature Medicine) · Read the original source ↗
Share this news




